Kate Rowbotham

Kate Rowbotham has been General Manager of the Roche UK affiliate since May 2025. 

In this role, Kate provides vision, financial stewardship, and strategic focus to ~1500 employees across multidisciplinary functions for pipeline and marketed products within the UK. She is accountable for the affiliate's profit and loss, in addition to its compliance with statutory regulations and corporate standards. She is an active member of the Roche Pharmaceutical International Network Enabling Team.

Kate is known as a visionary, results-oriented leader, and as a catalyst for change.

Most recently, Kate led the Customer Engagement organization at Genentech, Roche’s US subsidiary, overseeing ~1400 employees across multiple national, regional, and local teams that engage with healthcare providers, patients, payers, distributors and other Genentech customers. Her responsibility spanned the entire Genentech portfolio of products, delivering ~$25B in annual revenue in the US. 

She joined Genentech in 2005 and led a number of different Commercial Teams across Genentech’s Immunology and Oncology therapeutic areas. She has had responsibility for product launches, line extensions, and leadership of portfolio assets from strategy to execution. 

Kate began her career in the industry at Biogen in 2001.

She holds a Bachelor of Science in Chemical Engineering from Tufts University and a Master of Business Administration from the Tuck School of Business at Dartmouth College. Originally from the East Coast, Kate lived in the San Francisco Bay Area for 15 years. She currently resides in the UK with her husband, Chase, and her two boys, Jack and Finn.